DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Hillmen P. et al.
Alemtuzumab compared with chlorambucil as first-line therapy
for chronic lymphocytic leukemia.
J Clin Oncol 2007; 25 (35) 5616-23
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.